Home / Doxorubicin / Canada
CA ATC L01DB01 · updated 2 Nov 2026
Doxorubicin shortage in Canada
Is there a Doxorubicin shortage in Canada?
Yes. As of 2 Nov 2026, 5 Doxorubicin products are reported short in Canada, the first since 6 Jun 2024. The company estimate for the return is 31 Dec 2028. Main reason: manufacturing problem.
Also short in Germany, Italy, Ireland, Austria, Belgium, Czechia, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | DOXORUBICIN HYDROCHLORIDE INJECTION (5ml) | TEVA CANADA LIMITED | 6 Jun 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DOXORUBICIN INJECTION, BP (5ML) | ACCORD HEALTHCARE INC | 1 May 2025 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | DOXORUBICIN HYDROCHLORIDE INJECTION (100ML) | TEVA CANADA LIMITED | 6 May 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP (1x1 Vial) anticipated | PFIZER CANADA ULC | 23 Jun 2028 | 31 Dec 2028 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP (1X1 Vial) anticipated | PFIZER CANADA ULC | 23 Jul 2028 | 31 Dec 2028 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.